AbCellera Biologics Inc (ABCL)
2.83
-0.12
(-4.07%)
USD |
NASDAQ |
Nov 26, 16:00
2.825
0.00 (0.00%)
After-Hours: 20:00
AbCellera Biologics Price to Book Value: 0.7753 for Nov. 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 26, 2024 | 0.7753 |
| November 25, 2024 | 0.8082 |
| November 22, 2024 | 0.7562 |
| November 21, 2024 | 0.7452 |
| November 20, 2024 | 0.7315 |
| November 19, 2024 | 0.7425 |
| November 18, 2024 | 0.726 |
| November 15, 2024 | 0.726 |
| November 14, 2024 | 0.7562 |
| November 13, 2024 | 0.80 |
| November 12, 2024 | 0.811 |
| November 11, 2024 | 0.863 |
| November 08, 2024 | 0.7397 |
| November 07, 2024 | 0.7452 |
| November 06, 2024 | 0.7562 |
| November 05, 2024 | 0.7452 |
| November 04, 2024 | 0.7918 |
| November 01, 2024 | 0.7479 |
| October 31, 2024 | 0.7479 |
| October 30, 2024 | 0.7611 |
| October 29, 2024 | 0.7748 |
| October 28, 2024 | 0.7912 |
| October 25, 2024 | 0.7447 |
| October 24, 2024 | 0.7392 |
| October 23, 2024 | 0.7611 |
| Date | Value |
|---|---|
| October 22, 2024 | 0.7775 |
| October 21, 2024 | 0.7584 |
| October 18, 2024 | 0.7857 |
| October 17, 2024 | 0.7337 |
| October 16, 2024 | 0.7173 |
| October 15, 2024 | 0.7009 |
| October 14, 2024 | 0.6899 |
| October 11, 2024 | 0.7091 |
| October 10, 2024 | 0.6844 |
| October 09, 2024 | 0.6817 |
| October 08, 2024 | 0.7036 |
| October 07, 2024 | 0.72 |
| October 04, 2024 | 0.6844 |
| October 03, 2024 | 0.679 |
| October 02, 2024 | 0.679 |
| October 01, 2024 | 0.7036 |
| September 30, 2024 | 0.7118 |
| September 27, 2024 | 0.6923 |
| September 26, 2024 | 0.679 |
| September 25, 2024 | 0.6472 |
| September 24, 2024 | 0.6684 |
| September 23, 2024 | 0.6578 |
| September 20, 2024 | 0.687 |
| September 19, 2024 | 0.7267 |
| September 18, 2024 | 0.7294 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6339
Minimum
Sep 06 2024
175.28
Maximum
Dec 11 2020
4.960
Average
2.165
Median
Price to Book Value Benchmarks
| Aurinia Pharmaceuticals Inc | 3.214 |
| Edesa Biotech Inc | 2.503 |
| Lexaria Bioscience Corp | 3.327 |
| InMed Pharmaceuticals Inc | 0.3875 |
| Xenon Pharmaceuticals Inc | 4.057 |
Price to Book Value Related Metrics
| PS Ratio | 25.16 |
| PEG Ratio | -0.1305 |
| Price | 2.83 |
| Earnings Yield | -21.55% |
| Market Cap | 835.89M |
| PEGY Ratio | -0.1305 |